SHANGHAI -- One of China's COVID-19 vaccines gained crucial recognition Friday, nearly one year after its debut, as the World Health Organization approved the shot for emergency use.
The SARS-CoV-2 vaccine by China National Biotec Group (CNBG) -- a unit of state-owned Sinopharm -- joined five Western peers on the WHO's emergency list.
